Skip to main content
Clinical Trials/NCT03341416
NCT03341416
Unknown
Not Applicable

Deep Brain Stimulation on Cerebellar Ataxia

University of Sao Paulo General Hospital1 site in 1 country10 target enrollmentSeptember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebellar Ataxia
Sponsor
University of Sao Paulo General Hospital
Enrollment
10
Locations
1
Primary Endpoint
Primary outcome - change in Scale for the assessment and rating of ataxia - SARA
Last Updated
8 years ago

Overview

Brief Summary

Cerebellar ataxias are a group of disorders caused by cerebellar affections, for which currently no specific treatment is available. Some limited studies verified the effects of cerebellar transcranial magnetic stimulation (TMS) on ataxic symptoms, with good results. The hypothesis is that cerebellar TMS could improve ataxic symptoms in some patients and in these patients, chronic cerebellar stimulation through deep brain stimulation could be a therapeutic option. The rationale is to stimulate the dentate nucleus of the cerebellum in order to balance the functional asymmetry observed between both motor cortices after chronic cerebellar lesions.

Detailed Description

Ten patients with cerebellar ataxia will be included in our protocol. Ataxia might be due to several aetiologies, from degenerative to genetic and vascular diseases. The initial focus is vascular and spinal cerebellar ataxias. The participants will be submitted to a neuronavigation protocol for the precise location of the dentate nucleus contralateral to the most symptomatic side. After that, the participants will be randomly assigned to 5 active or 5 placebo sessions of 1Hz TMS over the located area. After the first 5 sessions and a period of at least 4 weeks washout, the participants will cross over and receive other 5 sessions, active or sham. Clinical and video evaluations will be conducted before and after active and sham cluster of sessions. The good responders, i.e., with over than 30% of improvement after the active section will be eligible to bilateral dentate nucleus DBS. After that, again, a cross-over double blind on-off stimulation will be performed. Each period (on or 0ff-stimulation) will last 4 weeks.

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
January 1, 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rubens Gisbert Cury

Medical Assistant, Movement Disorders Unit. Principal Investigator. MD, PhD

University of Sao Paulo General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with diagnosis of chronic cerebellar ataxia (\> 6 months);
  • Age ≥18 years;
  • Be able to understand study protocol;
  • Signed, written informed consent (approved by the Institutional Ethics Committee) obtained prior to any study procedure;
  • Refractory symptoms response to first, second and third line pharmacological treatment;
  • Daily living activities impaired because the ataxia;
  • Be able to undergo surgery procedures.

Exclusion Criteria

  • Abuse of alcohol, drugs
  • Known psychiatric conditions
  • Contraindications to DBS
  • Heart failure or cardiac disease that contraindicates surgery procedures;
  • Pacemaker or other stimulators implanted active;
  • Positive blood ß-HCG test for women;
  • Other medical conditions demand hospitalization; Participation in other clinical studies at the same time;

Outcomes

Primary Outcomes

Primary outcome - change in Scale for the assessment and rating of ataxia - SARA

Time Frame: change in the SARA score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.

To evaluate prospectively the effect of DN-DBS in ataxia. The primary outcome is the change between the Scale for the assessment and rating of ataxia (SARA, ranging from 0-40, higher scores mean more severe ataxia) at baseline and after surgery during the active DBS-ON phase

Secondary Outcomes

  • Secondary outcome - quality of life(change in the WHOQOL-bref score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.)
  • Secondary outcome - change in tremor score using the Fahn Tolosa Marin Scale(change in the Fahn Tolosa Marin Scale score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.)

Study Sites (1)

Loading locations...

Similar Trials